Carl Zeiss Meditec AG (ETR: AFX)

Market Cap	4.08B
Revenue (ttm)	2.07B
Net Income (ttm)	178.73M
Shares Out	87.54M
EPS (ttm)	2.01
PE Ratio	23.18
Forward PE	21.36
Dividend	0.60 (1.29%)
Ex-Dividend Date	n/a

Volume	142,176
Open	46.38
Previous Close	46.38
Day's Range	46.28 - 47.30
52-Week Range	45.02 - 123.75
Beta	0.98
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 11, 2024

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1846
• Employees: 4,823
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: AFX

Financial Performance

In 2024, Carl Zeiss Meditec AG's revenue was 2.07 billion, a decrease of -1.11% compared to the previous year's 2.09 billion. Earnings were 178.73 million, a decrease of -38.45%.